Unraveling the Pore-Forming Steps of Pneumolysin from Streptococcus pneumoniae
Source abstract
Abstract
Pneumolysin (PLY) is the main virulence factor of Streptococcus pneumoniae that causes pneumonia, meningitis, and invasive pneumococcal infection. PLY is produced as monomers, which bind to cholesterol-containing membranes, where they oligomerize into large pores. To investigate the pore-forming mechanism, we determined the crystal structure of PLY at 2.4 Å and used it to design mutants on the surface of monomers. Electron microscopy of liposomes incubated with PLY mutants revealed that several mutations interfered with ring formation. Mutants that formed incomplete rings or linear arrays had strongly reduced hemolytic activity. By high-resolution time-lapse atomic force microscopy of wild-type PLY, we observed two different ring-shaped complexes. Most of the complexes protruded ∼8 nm above the membrane surface, while a smaller number protruded ∼11 nm or more. The lower complexes were identified as pores or prepores by the presence or absence of a lipid bilayer in their center. The taller complexes were side-by-side assemblies of monomers of soluble PLY that represent an early form of the prepore. Our observations suggest a four-step mechanism of membrane attachment and pore formation by PLY, which is discussed in the context of recent structural models. The functional separation of these steps is necessary for the understanding how cholesterol-dependent cytolysins form pores and lyse cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Streptococcal Infections and Treatments · Lipid Membrane Structure and Behavior · Pneumonia and Respiratory Infections
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Structural Biology, Max PIanck Institute of Biophysics, Max von Laue Strasse 3, 60438 Frankfurt am Main, Germany
Department of Biosystems Science and Engineering, ETH Zurich, Mattenstrasse 26, 4058 Basel, Switzerland
Funding
Seventh Framework Programme · Swiss National Science Foundation
References (48)
Show source-provided references
1. 10.1016/j.coi.2015.04.00210.1016/j.coi.2015.04.002 ↗
2. Berry A. M. · Infect. Immun. · 1989 · 57 · 203710.1128/iai.57.7.2037-2042.1989 ↗
3. 10.1099/0022-1317-49-12-105710.1099/0022-1317-49-12-1057 ↗
4. Mitchell T. J. · Soc. Appl. Bacteriol. Symp. Ser. · 1997 · 83 · 62S10.1046/j.1365-2672.83.s1.7.x ↗
5. 10.1007/978-3-642-56508-3_110.1007/978-3-642-56508-3_1 ↗
6. 10.1007/BF0293127110.1007/BF02931271 ↗
7. 10.1128/IAI.73.10.6199-6209.200510.1128/IAI.73.10.6199-6209.2005 ↗
8. 10.1016/0014-5793(93)80050-510.1016/0014-5793(93)80050-5 ↗
9. 10.1007/BF0021994610.1007/BF00219946 ↗
10. 10.1007/978-3-642-56508-3_210.1007/978-3-642-56508-3_2 ↗
11. 10.1074/jbc.M30315120010.1074/jbc.M303151200 ↗
12. 10.1016/j.cell.2005.02.03310.1016/j.cell.2005.02.033 ↗
13. van Pee, K.; Neuhaus, A.; D’Imprima, E.; Mills, D. J.; Kühlbrandt, W.; Yildiz, Ö.CryoEM structures of membrane pore and prepore complex reveal cytolytic mechanism of Pneumolysin. Manuscript submitted, 2016.10.7554/eLife.23644.036 ↗
14. 10.1038/sj.emboj.760035010.1038/sj.emboj.7600350 ↗
15. 10.1093/emboj/17.6.159810.1093/emboj/17.6.1598 ↗
16. Bhakdi S. · Infect. Immun. · 1985 · 47 · 5210.1128/iai.47.1.52-60.1985 ↗
17. 10.7554/eLife.0424710.7554/eLife.04247 ↗
18. 10.1021/acs.nanolett.5b0296310.1021/acs.nanolett.5b02963 ↗
19. 10.1016/j.celrep.2013.04.02910.1016/j.celrep.2013.04.029 ↗
20. 10.1038/ncomms469010.1038/ncomms4690 ↗
21. 10.1038/srep1435210.1038/srep14352 ↗
22. 10.1038/srep1329310.1038/srep13293 ↗
23. 10.1016/S0092-8674(00)80251-210.1016/S0092-8674(00)80251-2 ↗
24. 10.1073/pnas.070810410510.1073/pnas.0708104105 ↗
25. 10.1074/jbc.M70117320010.1074/jbc.M701173200 ↗
26. 10.1083/jcb.20020108110.1083/jcb.200201081 ↗
27. 10.1073/pnas.050055810210.1073/pnas.0500558102 ↗
28. 10.1016/j.jsb.2005.02.00310.1016/j.jsb.2005.02.003 ↗
29. 10.1073/pnas.142375411210.1073/pnas.1423754112 ↗
30. 10.1107/S002188989300558810.1107/S0021889893005588 ↗
31. 10.1107/S090744490604597510.1107/S0907444906045975 ↗
32. 10.1107/S090744499400311210.1107/S0907444994003112 ↗
33. 10.1107/S090904950302393810.1107/S0909049503023938 ↗
34. 10.1107/S090744499601225510.1107/S0907444996012255 ↗
35. 10.1107/S090744490401915810.1107/S0907444904019158 ↗
36. 10.1007/978-1-60327-058-8_2810.1007/978-1-60327-058-8_28 ↗
37. DeLano W. L. · Abstr. Pap. Am. Chem. S. · 2004 · 228 · U313
38. 10.1016/0168-1656(95)00138-710.1016/0168-1656(95)00138-7 ↗
39. 10.1038/nmeth.260210.1038/nmeth.2602 ↗
40. 10.1038/nprot.2014.07010.1038/nprot.2014.070 ↗
41. 10.1021/la052687c10.1021/la052687c ↗
42. 10.1006/jsbi.1997.387510.1006/jsbi.1997.3875 ↗
43. 10.1006/jmbi.1995.029210.1006/jmbi.1995.0292 ↗
44. 10.1021/la970221r10.1021/la970221r ↗
45. 10.1038/nprot.2007.30910.1038/nprot.2007.309 ↗
46. 10.1016/S0006-3495(97)78195-510.1016/S0006-3495(97)78195-5 ↗
47. Israelachvili J. · 1991
48. 10.1046/j.1365-2818.2002.01039.x10.1046/j.1365-2818.2002.01039.x ↗